(Q39627643)

13 September 2017

title

Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia (English)

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

23 April 2022

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

23 April 2022

lymphoblastic leukemia

1 reference

de Sijvarger SR

14

1 reference

13 September 2017

F. Sackmann-Muriel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

E. Svarch

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

M. Eppinger-Helft

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

J. L. Braier

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

S. Pavlovsky

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

L. Guman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

B. Vergara

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

C. Ponzinibbio

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

R. Failace

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

G. E. Garay

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

E. Bugnard

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

F. G. Ojeda

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

R. De Bellis

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

S. R. de Sijvarger

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

J. Saslavsky

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A101296

23 April 2022

language of work or name

English

0 references

publication date

1 October 1978

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

23 April 2022

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

23 April 2022

1 reference

13 September 2017

volume

42

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

1730-1740

1 reference

A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia

13 September 2017

cites work

2

29

381

Aur

1972

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

Comparison of prednisolone, vincristine, methotrexate, and 6-mercaptopurine vs. vincristine and prednisone induction therapy in childhood acute leukemia

23 April 2022

5

36

98

Berry

1975

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

Maximum utilization of the life table method in analyzing survival

23 April 2022

0 references

The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

13

26

404

Evans

1970

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

Immunocompetence and prognosis in children with acute lymphoblastic leukemia: combination of two different maintenance therapies

23 April 2022

15

2

403

Garay

1976

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

A generalized Wilcoxon test for comparing arbitrarily singly-censored samples

23 April 2022

16

52

203

Gehan

1965

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

Factors influencing survival in pediatric acute leukemia.The SWCCSG experience, 1958–1970

23 April 2022

17

32

1542

George

1973

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

Parenchymatous degeneration of the central nervous system in childhood leukemia

23 April 2022

18

33

468

Hendin

1974

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

23 April 2022

19

31

1319

Holland

1971

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

Oncologists' Reply: Survival Expectancy in Acute Lymphocytic Leukemia

23 April 2022

20

287

769

Holland

1972

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

Cyclophosphamide-asparaginase- vincristine-prednisone induction therapy in childhood acute lymphocytic and nonlymphocytic leukemia

23 April 2022

24

37

1243

Komp

1976

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

Additive therapy in the maintenance of remission in acute lymphoblastic leukemia of childhood: the effect of the initial leukocyte count

23 April 2022

26

34

508

Miller

1974

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

23 April 2022

27

37

535

Ortega

1977

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

Induction and maintenance of remission in acute leukemia. Effectiveness of combination therapy in 227 patients

23 April 2022

28

31

273

Pavlovsky

1973

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

Treatment of acute leukemia

23 April 2022

30

23

117

Pinkel

1976

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

The central nervous system in childhood leukemia.II. Subacute leukoencephalopathy

23 April 2022

31

35

306

Price

1975

0 references

Disseminated necrotizing leukoencephalopathy: a complication of treated central nervous system leukemia and lymphoma

32

35

291

Rubinstein

1975

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

Evaluation of induction of remission, intensification, and central nervous system prophylactic treatment in acute lymphoblastic leukemia

23 April 2022

34

34

418

Sackmann-Muriel

1974

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

Remission induction in adult acute lymphocytic leukemia. Use of vincristine and prednisone alone

23 April 2022

35

38

672

Scavino

1976

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

Factors that influence haematological remission duration in acute lymphocytic leukaemia

23 April 2022

36

32

465

Simone

1976

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

Initial features and prognosis in 363 children with acute lymphocytic leukemia

23 April 2022

37

36

2099

Simone

1975

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

The Concept of Immunological Surveillance

23 April 2022

8

1 reference

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

https://api.crossref.org/works/10.1002/1097-0142(197810)42:4%3C1730::AID-CNCR2820420411%3E3.0.CO;2-K

24 November 2022

Identifiers

10.1002/1097-0142(197810)42:4<1730::AID-CNCR2820420411>3.0.CO;2-K

1 reference

13 September 2017

1 reference